US Regulators Post Positive Review Of Pfizer Vaccine Data

FILE - In this Nov. 9, 2020, file photo, pedestrians walk past Pfizer world headquarters in New York. Pfizer said Friday, Nov. 20, 2020, it is asking U.S. regulators to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month and eventually an end to the pandemic -- but not until after a long, hard winter. (AP Photo/Bebeto Matthews, File)

(AP) — U.S. health regulators have posted a positive review of Pfizer’s COVID-19 vaccine as they near a decision on whether to allow use of the shot. The review posted online Tuesday by the Food and Drug Administration offers the world the first detailed look at the evidence behind the shot, which was co-developed with BioNTech. FDA scientists said the shots worked well in older adults, a key group. The FDA review comes before a Thursday meeting where a panel of independent experts will scrutinize the data and vote on whether to recommend use of the vaccine. A U.S. decision to authorize the vaccine is expected within days.

Studies Suggest AstraZeneca COVID-19 Vaccine Safe, Effective

Previous article

US Productivity Increased At 4.6% Rate In Third Quarter

Next article

You may also like